Henderson Smaller Companies Investment Trust PLC (HSL.L) stock: key figures, P/E, revenue and dividend
Financials · United Kingdom · ISIN GB0009065060
Henderson Smaller Companies Investment Trust PLC financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | -38.00 m GBP | 59.90 m GBP |
| Gross profit | -44.00 m GBP | 57.90 m GBP |
| Operating income | – | 56.81 m GBP |
| EBIT | -44.00 m GBP | – |
| Net income | -44.00 m GBP | 53.65 m GBP |
| Diluted EPS – continuing operations | -0.61 GBP | 0.88 GBP |
Full history since 1998, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Henderson Smaller Companies Investment Trust PLC
The Henderson Smaller Companies Investment Trust plc is a closed-ended equity mutual fund launched and managed by Henderson Investment Funds Limited. It is co-managed by Henderson Global Investors Limited. The fund invests in the public equity markets of the United Kingdom. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a bottom-up stock picking approach, focusing on factors such as management quality, financial structure, balance sheet, cash flow, and earnings to create its portfolio. The fund benchmarks the performance of its portfolio against the NUMIS Smaller Companies (ex Investment Companies) Index. The Henderson Smaller Companies Investment Trust plc was formed on December 16, 1887 and is domiciled in the United Kingdom.
More stocks
- EASTMAN KODAK CO (KODK)
- Jastrzebska Spolka Weglowa SA (JSW.WA)
- CTO Realty Growth, Inc. (CTO)
- FINANCIAL INSTITUTIONS INC (FISI)
- Pharming Group NV (PHARM.AS)
- Tinexta S.p.a (TNXT.MI)
- PSI Software (PSAN.DE)
- GemLife Communities Group (GLF.AX)
- Shenzhen Topraysolar Co Ltd (002218.SZ)
- FIDUS INVESTMENT Corp (FDUS)
- Xianheng International Science & Technology Co Ltd (605056.SS)
- Alphamab Oncology (9966.HK)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.